Inflammatory mediator in the skin

The term "inflammatory mediators in the skin" refers to a diverse group of molecules—including cytokines (such as interleukins and tumor necrosis factor alpha), chemokines, growth factors, neuropeptides (like substance P and CGRP), eicosanoids (such as prostaglandins and leukotrienes), histamine, and antimicrobial peptides—that are produced by various cell types within the skin including keratinocytes, mast cells, macrophages, T cells, sebocytes and others[1][2][4][5][6]. These molecules orchestrate immune responses to injury or infection by recruiting immune cells to sites of damage or pathogen invasion[2][6], regulating vascular permeability[1], promoting cell proliferation and migration during wound healing[4], modulating pain/itch sensation via neuronal activation[1], and maintaining tissue homeostasis. Dysregulation of these mediators contributes to chronic inflammatory diseases such as psoriasis or atopic dermatitis[3][6]. Because "inflammatory mediators in the skin" is not a single molecule but rather an umbrella term for many different signaling entities with distinct molecular identities and functions—some pro-inflammatory (e.g., IL‑1β) and some anti-inflammatory—the entry does not correspond to a canonical therapeutic target like an enzyme or receptor. Instead it describes a functional category encompassing multiple targets that may be individually druggable. Therefore: > The entry "Inflammatory mediators in the skin" is too broad/vague for structured data about a single molecular target. It should be replaced with entries for individual well-defined molecules such as "Interleukin 1 beta", "Tumor necrosis factor alpha", "Histamine receptor H1", etc.[4][7] If you need information on any *specific* inflammatory mediator relevant to cutaneous biology—such as interleukin 17A or substance P—I can provide detailed structured data accordingly.

Other names

Pro-inflammatory mediator in the skinAnti-inflammatory mediator in the skinCutaneous inflammatory mediators

Varies by specific mediator; for example, cytokine inhibition or receptor antagonism.